- 01PSA measures the prostate, not prostate cancer
Prostate-specific antigen is made by the whole prostate gland, so an enlarged, inflamed, or recently disturbed prostate raises it much as a cancer would. Most high PSAs are benign, and no PSA level, high or low, confirms or rules out cancer on its own.
- 02'Normal' is age-shaped, and 4.0 was never a bright line
The old 4.0 ng/mL cutoff is a convention, not a wall between safe and dangerous. PSA drifts up with age as the prostate grows, and about 15% of men below 4.0 still had cancer in the Prostate Cancer Prevention Trial, which is why clinicians read the number as a range plus a trend, refined by follow-up tests (free-PSA percentage and PSA density, explained below).
- 03PSA screening is a genuine shared decision
PSA is the one tumor marker used to screen people without symptoms, and even that is debated: finding some cancers early comes bundled with overdiagnosing and overtreating many that would never have caused harm. Bodies like the USPSTF frame it as a personal choice for men roughly 55 to 69, so it is a conversation with a clinician, not an automatic test.
A PSA test measures prostate-specific antigen, a protein made by the prostate gland. It reads the prostate itself, which is why a raised result so often has nothing to do with cancer. A prostate that is enlarged, inflamed, or recently disturbed by sex or a bike saddle pushes PSA up just as readily. A high PSA is common in men without cancer, and a normal PSA clears no one.
What is a PSA test?
Prostate-specific antigen, or PSA, is a protein the prostate makes to keep semen liquid. A small amount leaks into the blood normally, and a PSA test measures that amount in nanograms per milliliter (ng/mL). Because every part of the prostate produces it, the number rises whenever the gland is enlarged, irritated, or damaged, whether or not any of that involves cancer 5.
This is the trap built into every tumor marker, the substances labs measure to follow cancers. A tumor marker is produced by healthy tissue too, so a single value means little on its own 1.
A tumor marker is not a cancer test: it is a substance cancer cells and healthy cells both make, and benign conditions raise most of them.
What is a normal PSA level?
There is no PSA level that means 'safe' and none that means 'cancer.' For years, 4.0 ng/mL was treated as the cutoff between normal and high, but that line was always a rough convention. In the Prostate Cancer Prevention Trial, about 15% of men with a PSA at or below 4.0 still had prostate cancer on biopsy, and some of those cancers were aggressive 4. Labs and clinicians now read PSA as a range shaped by your age, your prostate size, and how the number is trending, rather than a single pass-fail mark 5.
| Total PSA (ng/mL) | How it is commonly read | Typical next step |
|---|---|---|
| Under 4.0 | Historically labeled 'normal,' though no level rules cancer out | Interpreted alongside age and any prior PSA results |
| 4.0 to 10.0 | The 'gray zone,' where most results turn out benign | Often repeated; free-PSA percentage, PSA density, or MRI may refine it |
| Above 10.0 | Higher likelihood of a prostate problem, still not a diagnosis | Prompt evaluation by a urologist |
The 4.0 ng/mL mark is a historical convention, not a diagnostic cutoff, and roughly 15% of men at or below it had prostate cancer in the PCPT trial 4; there is no single 'normal' PSA 5.
PSA levels by age
The prostate enlarges with age, so PSA tends to climb even when nothing is wrong. To account for that, many labs apply age-specific upper reference values, so the same 3.5 ng/mL that is unremarkable at 65 may prompt a second look at 45. The numbers below are one widely used set, the classic age-specific reference ranges published by Oesterling and colleagues; exact values differ by lab, and none of them is a diagnostic threshold 6.
| Age | Commonly used upper reference (ng/mL) |
|---|---|
| 40 to 49 | 2.5 |
| 50 to 59 | 3.5 |
| 60 to 69 | 4.5 |
| 70 to 79 | 6.5 |
Where an example PSA of 5.5 falls (age-dependent, not a diagnosis)ng/mL
What causes a high PSA?
Anything that irritates, enlarges, or disturbs the prostate can raise PSA. The most common reason by far is benign prostatic hyperplasia (BPH), the ordinary enlargement of the gland that comes with age. Prostatitis (inflammation or infection of the prostate) and urinary tract infections push it up too, and so do recent events before the blood draw: ejaculation and a long or hard bike ride in the days beforehand are the ones worth avoiding, while a routine digital rectal exam (a clinician's gloved-finger check of the prostate) has only a minimal, usually clinically insignificant effect. Cancer is one possible cause among these, and usually not the one behind a mildly raised number 5.
A raised PSA: how clinicians sort the likely causes
Does a high PSA mean cancer?
No. A high PSA raises the question of cancer without answering it, because benign causes account for most elevations. The reverse is also true: a low PSA is reassuring but not a guarantee. In the Prostate Cancer Prevention Trial, roughly 15% of men whose PSA sat at 4.0 ng/mL or below were found to have prostate cancer on biopsy, and about 15% of those cancers were high grade 4. That is why no PSA number, high or low, settles the question by itself.
The refinements clinicians use when PSA is borderline
When a total PSA lands in the gray zone with a prostate that feels benign, clinicians rarely jump to a biopsy. They add tests that split the same number into more informative pieces. The best known is the free-to-total PSA ratio: PSA travels in the blood either bound to proteins or unbound ('free'), and a higher share of free PSA points toward a benign gland 3.
- Free-PSA percentage: the share of PSA that is unbound. In the gray zone, a higher percentage leans benign; Catalona's 1998 study found a 25% cutoff caught 95% of cancers while sparing about 1 in 5 men an unnecessary biopsy 3.
- PSA density: the PSA divided by the prostate's volume on imaging. A big gland can explain a big number, so a lower density is more reassuring.
- PSA velocity: how fast PSA changes over time. A number creeping up across several tests draws more attention than a one-off reading.
Reflex tests like the free-to-total PSA ratio exist to reduce unnecessary biopsies in the gray zone, not to replace a clinician's evaluation or to serve as a cancer test.
Should you get a PSA test? Weighing the benefit against the harm
Screening means testing people with no symptoms to catch disease early. PSA is the one tumor marker used this way at all, and even that use is debated, because catching some prostate cancers early comes bundled with finding many that would never have caused harm, then treating them with surgery or radiation that carries real side effects like incontinence and erectile dysfunction. The US Preventive Services Task Force weighed that tradeoff and framed PSA screening as a personal choice for men aged 55 to 69 (a grade C, meaning offer it case by case), and recommended against routine screening for men 70 and older (grade D, meaning likely more harm than benefit) 2.
the decision to undergo periodic ... screening for prostate cancer should be an individual one and should include discussion of the potential benefits and harms of screening with their clinician.US Preventive Services Task Force, JAMA, 2018
Higher-risk groups, including Black men and men with a father or brother who had prostate cancer, are often encouraged to start that conversation earlier, but the starting point is the same: a discussion with a clinician about your own risk and preferences, rather than an automatic yearly test. LifeFrom does not tell you whether to screen; it helps you walk into that conversation understanding what the number can and cannot do.
How a PSA test is done, and how often
- It is a simple blood draw, usually from the arm, and does not require fasting.
- PSA is often ordered on its own or alongside a prostate exam; it is not part of a standard cholesterol or metabolic panel, so it has to be requested.
- In the US it is inexpensive and widely available; when done as recommended screening it is frequently covered, though coverage varies, so it is worth checking your plan.
- Retesting cadence is individualized. Because ejaculation, cycling, and a recent exam or infection can inflate a reading, a raised result is commonly rechecked in a few weeks under calmer conditions before any next step.
A PSA result earns its meaning next to your age, your prior numbers, and a clinician's exam. Those together decide whether anything more is worth doing. On its own, a single value mostly generates worry it cannot resolve, so the sensible next move is to review it with the clinician who ordered it.
Citations
- National Cancer Institute, Tumor Markers in Common Use (2024).
- US Preventive Services Task Force, Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement, JAMA 2018;319(18):1901-1913.
- Catalona WJ, Partin AW, Slawin KM, et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease, JAMA 1998;279(19):1542-1547.
- Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level of 4.0 ng per milliliter or lower, New England Journal of Medicine 2004;350:2239-2246.
- National Cancer Institute, Prostate-Specific Antigen (PSA) Test fact sheet.
- Oesterling JE, Jacobsen SJ, Chute CG, et al. Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges, JAMA 1993;270(7):860-864.
Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.